Skip to main content

Joint Heidelberg-IDC Translational Diabetes Program

Collaborative Research Center 1118

Collaborative Research Center 1118

About our research

The Joint Heidelberg-IDC Translational Diabetes Unit represents the translational and clinical arm of the IDC Diabetes activities and has been established in collaboration with the University Hospital Heidelberg, Germany, and the Collaborative Research Center 1118, funded by the Deutsche Forschungsgemeinschaft DFG.

This unit is co-directed by Peter Nawroth, Clinical director of the Inner Medicine I department at Heidelberg University Hospital, and IDC director Stephan Herzig and offers the opportunity to directly transfer findings from the IDC research divisions into clinical practice.

A particular focus is placed on therapies geared towards the remission of diabetes long-term complications and combinatorial therapies against conditions of chronic malnutrition, supported by both patient-derived biobanks and clinical trials.

Our Team

Prof. Dr. med. univ. Julia Szendrödi

Medical Director of the Clinic for Endocrinology, Diabetology, Metabolic Diseases and Clinical Chemistry at Heidelberg University Hospital
Portrait von Bilgen Ekim

Dr. Bilgen Ekim

Junior Group Leader Heidelberg

Sevgican Demir

Postdoc
Wolff Gretchen Porträt IDC

Dr. Gretchen Wolff

Postdoc

Annika Wieder

Technische Assistentin

Our Most Recent Publications

Read more

2023 Scientific Article in Hepatology

De Angelis Rigotti, F. ; Wiedmann, L. ; Hubert, M.O. ; Vacca, M. ; Hasan, S.S. ; Moll, I. ; Carvajal, S. ; Jiménez, W. ; Starostecka, M. ; Billeter, A.T. ; Müller-Stich, B. ; Wolff, G. ; Ekim Üstünel, B. ; Herzig, S. ; Fandos-Ramo, C. ; Krätzner, R. ; Reich, M. ; Keitel-Anselmino, V. ; Heikenwälder, M. ; Mogler, C. ; Fischer, A. ; Rodriguez-Vita, J.

Semaphorin 3C exacerbates liver fibrosis.

Contact Us

Portrait von Bilgen Ekim

Dr. Bilgen Ekim

Junior Group Leader Heidelberg